Welcome to Agile R100
Reliable kinetic binding data at your benchtop… and under your control.
The easy-to-learn label-free Agile R100 assay makes it simple to get kinetic binding data earlier in the drug discovery process when you need it most. Built with highly sensitive, proprietary Field Effect Biosensing (FEB) technology, Agile R100 enables you to gain on and off rates and affinity rankings at the comfort of your benchtop, giving you complete control over the characterization of your biomolecules.
Validate your hits with a novel orthogonal approach and achieve measurements never before possible!
SENSITIVE LABEL-FREE RESULTS WITH AGILE R100
Agile R100’s open-pipetting design enables on-the-fly assay modification, vastly reducing assay development time.
See how it’s used in this 1:32 video!
NEW PUBLICATION ON FEB SIGNAL-TO-NOISE RATIO COMPARED TO BLI AND ELISA
Agile R100, a Field Effect Biosensing (FEB) system, detected Zika viral antigen at a concentration 10 times lower than on a BLI system in this breakthrough study. The platform also lowered the limit of detection by 10 times versus on an ELISA for inflammatory protein IL-6.
Join us to learn more about the Agile R100 orthogonal approach to biophysical characterization!
We’ll be in Booth 332 at the 2018 the Society for Laboratory Automation and Screening (SLAS) conference in San Diego from Feb. 3-7 to launch Agile R200, the only high-throughput biophysical data platform compatible with automated liquid handlers.